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Background: Ventricular arrhythmias play an important role in cardiovascular mortality especially in patients with
impaired cardiac and autonomic function. The aim of this experimental study was to determine, if renal
denervation (RDN) could decrease the inducibility of ventricular fibrillation (VF) in a healthy porcine biomodel.
Methods: Controlled electrophysiological study was performed in 6 biomodels 40 days after RDN (RDN group) and
in 6 healthy animals (control group). The inducibility of VF was tested by programmed ventricular stimulation from
the apex of right ventricle (8 basal stimuli coupled with up to 4 extrastimuli) always three times in each biomodel
using peripheral extracorporeal oxygenation for hemodynamic support. Further, basal heart rate (HR), PQ and QT
intervals and effective refractory period of ventricles (ERP) were measured. Technical success of RDN was evaluated
by histological examination.
Results: According to histological findings, RDN procedure was successfully performed in all biomodels. Comparing
the groups, basal HR was lower in RDN group: 79 (IQR 58; 88) vs. 93 (72; 95) beats per minute (p = 0.003); PQ interval
was longer in RDN group: 145 (133; 153) vs. 115 (113; 120) ms (p < 0.0001) and QTc intervals were comparable: 402
(382; 422) ms in RDN vs. 386 (356; 437) ms in control group (p = 0.1). ERP was prolonged significantly in RDN group:
159 (150; 169) vs. 140 (133; 150) ms (p = 0.001), but VF inducibility was the same (18/18 vs. 18/18 attempts).
Conclusions: RDN decreased the influence of sympathetic nerve system on the heart conduction system in healthy
porcine biomodel. However, the electrophysiological study was not associated with a decrease of VF inducibility after RDN.
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The occurrence of ventricular arrhythmias is influenced
by the activity of the autonomic nervous system [1]. The
sympathetic nervous system plays an important role in
the onset, maintenance and termination of ventricular
arrhythmia. Most typically sympathetic activation enhances
ventricular arrhythmia while vagal tone suppresses its
occurrence. The onset of ventricular arrhythmias is* Correspondence: jean-claude.lubanda@vfn.cz
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unless otherwise stated.provoked by shortening the effective ventricular refractory
time, being a result of sympathetic stimulation. Therefore
modulating the activity of the autonomic nervous system
might suppress the incidence of ventricular arrhythmias
including ventricular fibrillation and provide a rationale
for the reduction of the risk of sudden cardiac death.
Moreover, RDN was successfully used to reduce the
occurrence of electrical storm in many case reports.
Impaired cardiac autonomic control and increased
sympathetic tone by physical or emotional stress play
an important role in the induction of arrhythmia [2]
and increase the risk of sudden death [3]. Moreover,
increased sympathetic activity as a result of cardiacal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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heart failure and increased mortality [4,5]. Therefore
the use of beta adrenergic blocking agents is generally
recommended as prophylaxis of malignant ventricular
arrhythmias to reduce the risk of sudden cardiac death
[6,7]. However, some invasive procedures can modulate
the tone of sympathetic nerves. Surgical ablation of the
lower part of the left ganglion stellate and the first four
thoracic ganglia (left cardiac sympathetic denervation)
reduces the rate of cardiac events refractory to therapy in
most patients with inherited arrhythmia syndromes,
such as long-QT syndrome and cathecholaminergic
polymorphic ventricular tachycardia (VT) [8]. The potential
effects of renal denervation for the reduction of malignant
arrhythmia has been described. And its potential benefit is
being discussed in heart failure patients with left ventricle
dyssynchrony which is independently associated with the
risk of sudden cardiac death [9]. Moreover, catheter-based
approach has been developed for renal sympathetic
denervation (RDN) using several techniques [10]. The
ablation procedure reduces sympathetic activation not
just in the kidney but also in the whole body [11-13].
Beyond lowering of blood pressure RDN was shown
to reduce the resting heart rate and to prolong PR
interval in patients with resistant arterial hypertension
[14]. Also in a pig model of atrial fibrillation RDN reduced
duration of pacing-induced episodes of the arrhythmia
[15]. Moreover, stimulation of left stellate ganglion and
rapid atrial pacing in animals after RDN did not increase
the inducibility of atrial fibrillation [16]. Similar findings
were described in patients after pulmonary vein isolation
along with RDN who experienced significantly fewer
episodes of atrial fibrillation at follow-up than patients
after pulmonary vein isolation alone [17]. Focused on
ventricular arrhythmias, Linz et al. [18] reported a signifi-
cant reduction of spontaneous ventricular extrabeats and
ventricular fibrillation (VF) episodes during acute myocar-
dial ischemia and reperfusion in dogs after RDN. According
to case reports, a significant decrease of VT/VF was
observed in two patients with dilated and hypertrophic
cardiomyopathy and in a patient after acute myocardial
infarction who all suffered from treatment-resistant
electrical storms [19,20]. The objective of this experimentalFigure 1 Overall scheme of the study. RDN indicates renal denervation;
EP, electrophysiological.study was to compare changes of electrophysiological
parameters and inducibility of VF in a healthy porcine
biomodel 40 days after RDN with a control group.
Methods
The experimental protocol was designed to perform the
controlled study in 6 biomodels 40 days after RDN
(RDN group) and in 6 healthy animals (control group).
The electrophysiological (EP) study was performed using
catheter based techniques. The peripheral veno-arterial
extracorporeal membrane oxygenation (ECMO) was used
because of myocardial protection during the ventricular
pacing and arrhythmias. An overall scheme of the study is
shown in Figure 1.
Cross-bred swine (Landrace x White; 44 ± 3 kg) were
used for the experiments in an accredited experimental
university laboratory by a skilled team of clinicians and
veterinary specialists. The animals were handled in
accordance with the guidelines of research animal use
[21]. The protocol was approved by the Charles University
1st Medical School Institutional Animal Care and Use
Committee and performed at the Animal Laboratory,
Institute of Physiology, 1st Medical School, Charles
University in Prague in accordance with Act No 246/
1992 as amended, Collection of Laws, Czech Republic,
that is harmonized with EU Directives 86/609/EEC as
amended, 2007/526/ES, 2010/63/EU.
Anesthesia and monitoring
The pigs were sedated by intramuscular application of
azaperone (2–3 mg/kg) and ketamine (20 mg/kg). Then
the marginal ear vein was cannulated and general
anesthesia was induced by intravenous bolus of propofol
(1–2 mg/kg). After preoxygenation via facial mask,
orotracheal intubation was performed. During the
experiment were the biomodels mechanically ventilated
using Intellivent-ASV closed-loop system (G5, Hamilton
Medical, Bondauz, Switzerland) to maintain normoxia
(SpO2 98%) and normocapnia (EtCO2 38–40 mmHg)
respecting the actual metabolic rate. The total intravenous
anesthesia was maintained by continuous administration of
propofol (6–12 mg/kg/h) and morphine (0.1-0.2 mg/kg/h).
The depth of anesthesia was regularly assessed by theGA, general anesthesia; ECMO, extracorporeal membrane oxygenation;
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accordingly. Intravenous infusion of Ringer’s solution
was given to reach and maintain central venous pressure
between 6 and 8 mmHg. Anticoagulation was provided by
unfractionated heparin bolus (100 IU/kg IV) followed by
continuous intravenous drip (40–50 IU/kg/h) to maintain
target activated clotting time 180–250 seconds (values
checked every hour with Hemochron Junior+, International
Technidyne Corporation, Edison, NJ, USA). Sheaths and
catheters were inserted to femoral and carotid/jugular
vessels as needed. Invasive blood pressure from carotid and
pulmonary artery, central venous pressure (TruWave,
Edwards Lifesciences, USA), body surface ECG, capnometry
and pulse oximetry were continuously monitored by
bedside monitor (Life Scope TR, Nihon Kohden, Japan).
Renal denervation
After initiation of general anesthesia and mechanical
ventilation an 8 french sheath was placed into the right
common femoral artery under ultrasound guidance and
consequently another 6 french sheath was introduced
into the right common femoral vein. The later was used
for the acquisition of samples for biochemical analysis
during the procedure. According to the protocol, after
preliminary samples were withdrawn, renal angiography
was performed and an ablation catheter was then
introduced into the renal arteries. In 4 cases, the
EnligHTN catheter (St. Jude Medical, USA) was used
and in 2 cases we used the Symplicity catheter (Medtronic,
USA). The ablation procedure was performed according to
the instruction for use of each device in both arteries
in each case and the effect of the procedure was controlled
by a drop of impedance of at least 10%. At the end of
RDN procedure, the femoral sheath was extracted and
the groin was surgically sutured. Subsequently, the
administration of anesthetics and analgesics was
stopped and successful weaning from artificial ventilation
was achieved. Then were the animals extubated. For
next 40 days, the animals were bred in a certified
menagerie.Figure 2 Scheme of electrophysiological study. 8xS1 indicates the train
refractory period; VF, ventricular fibrillation; defib, defibrillation; ECMO high,
until the sinus rhythm was restored.Cardiopulmonary bypass
Before starting the EP study, cardiopulmonary bypass
(CPB) was established: an inlet 19 F cannula was
inserted via femoral vein into the right atrium and an
outlet 17 F cannula into abdominal aorta via femoral
artery. The cannulae were connected to ECMO circuit
consisting of a blood pump (Levitronix Centrimag,
Levitronix, USA) and oxygenator (Quadrox, Maquet,
Germany). The ECMO circuit was primed with 500 mL of
saline with 2500 IU of unfractionated heparin. The ECMO
blood flow was empirically set at 40 mL/kg/min to prevent
low cardiac output and hypotension during the ventricular
stimulation. After the onset of VF, the flow was increased
to 80-100 mL/kg/min as needed to keep mean arterial
pressure of 60 mmHg until an effective pulsatile sinus
rhythm with mean arterial pressure above 60 mmHg was
restored. Ventilation support, as well as ECMO gas flow,
was regularly adjusted to reach the target values (SpO2
98% and pCO2 38-40 mmHg).
Electrophysiological study
A diagnostic decapolar catheter (Response CSL, St. Jude
Medical, USA) was inserted under fluoroscopic guidance
into the apex of the right ventricle (RV) via right jugular
vein to provide monitoring of intracardial electrograms
and to induce VF. Five bipolar channels were recorded
from the apex to base of RV at 3 kHz sampling rate. VF
was induced by programmed ventricular stimulation
(PVS, Figure 2). Briefly, electrical stimuli (12 ms duration,
maximal stimulation current 20 mA) were delivered from
the apex of RV. Eight basic stimuli (S1) of cycle length
300, 350 or 400 ms according to the heart rate were
coupled with up to 4 extrastimuli (S2-S5). The coupling
interval of S2 was decreased at 10 ms steps until the
ventricular effective refractory period (ERP) was achieved.
S2 coupling interval was then set to 10 ms above ERP and
analogically S3 or S4 stimuli were delivered until VF was
reached. There were at least 10 s intervals between pacing
sequences. VF was defined as an orderless rhythm without
detectable QRS complexes lasting longer than 30 s.of eight basic stimuli; S2-5, up to five extrastimuli; ERP, effective
increasing of the ECMO flow to 80-100 mL/kg/min after onset of VF
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tion using pads placed in the conventional position
sternum - apex (TEC-5521, Nihon Kohden, Japan).
Biphasic shocks with rising energy (150-200-270 J)
were delivered as needed. Another PVS procedure was
performed at least 10 minutes after SR restoration in a
previous one.
Data acquisition protocol
The baseline surface ECG was acquired during 10 minutes
at minimum of 60 minutes after general anesthesia
initiation. Heart rate (HR), PQ and QT intervals were
assessed ten times (in each minute of the ECG record) by
offline manual analysis with appropriate time resolution
and QTc was calculated using Bazett’s formula (QT
interval divided by square root of RR interval). Then
was CPB established and ECMO connected. EP study
began at minimum of 30 minutes after connecting
ECMO. PVS procedures were performed three times
in each animal. Finally, an autopsy was carried out to obtain
samples of renal arteries and macroscopic and histological
assessment of the arterial wall and perirenal nerves.
All procedures were provided by a skilled pathologist.
Statistics
The sample size was calculated using Medcalc software
(Medcalc® Version 12,1.4.0) based on the primary
outcome of the study which was the inducibility of
VF. The number of attempts to induce VF was estimated
according the study by linz et al. [18] where VF occurredTable 1 Comparison of ECG and ventricular fibrillation (VF) in
Control group
Animal # HR (ms) PQ (ms) QTc (ms) Ind
1 89 (88; 91) 114 (113; 117) 361 (357; 364) 400
2 94 (93; 94) 118 (116; 118) 359 (356; 360) 350
3 96 (96; 98) 120 (116; 123) 438 (436; 444) 350
4 72 (72; 73) 113 (113; 113) 368 (367; 368) 350
5 95 (95; 95) 110 (108; 110) 353 (351; 355) 350
6 68 (67; 68) 143 (140; 144) 328 (326; 332) 300
Total 93 (72; 95) 115 (113; 120) 386 (356; 437)
RDN group
Animal # HR (ms) PQ (ms) QTc (ms) Ind
1 78 (78; 79) 123 (120; 124) 386 (383; 391) 400
2 81 (78; 85) 146 (143; 148) 389 (382; 400) 400
3 88 (87; 89) 149 (145; 153) 472 (466; 475) 350
4 49 (48; 49) 161 (158; 163) 356 (354; 358) 400
5 113 (113; 113) 131 (128; 133) 421 (416; 425) 350
6 58 (58; 59) 153 (150; 155) 405 (402; 407) 350
Total 79 (58; 88)** 145 (133; 153)*** 402 (382; 422)NS
Induction parameters represent minimal cycle lengths of basic stimuli and up to fiv
indicates heart rate; ERP, effective refractory period of ventricles; VF, ventricular fibrin 14% of denervated pigs and in 83% of sham treated
pigs. For each experiment, we planned 3 attempts. The
minimal required sample size per group for equal samples
sizes for alpha = 0.05 and power = 0.80 (beta = 0.20) was 5,
meaning 15 attempts per group assuming that the
data will be approximately normally distributed. Data
are presented as medians (interquartile ranges). The
nonparametric unpaired Mann–Whitney test was
used to assess the differences. The P values < 0.05
were considered significant. Statistical analysis and
graphs were performed using Prism 5.0 (GraphPad, La
Jolla, CA, USA).Results
The electrophysiological parameters and VF inducibility
data are summarized in Table 1 and Figure 3. According
to histological findings, destruction of perirenal nerves
was successful in both arteries in each case regardless of
used ablation catheter (Figure 4). No arterial stenosis or
endothelial damage was found 40 days after RDN.ECG changes at baseline
Comparing RDN and control group, basal HR was
significantly lower in RDN group: 79 (58; 88) vs. 93
(72; 95) beats per minute, p = 0.003. Accordingly, PQ
interval in RDN group was longer: 145 (133; 153) vs.
115 (113; 120) ms, p < 0.0001, and QTc intervals were
comparable between RDN and control group: 402 (382;
422) vs. 386 (356; 437) ms, p = 0.1.duction parameters of RDN and control group







140 (133; 150) 18/18 (100%)







159 (150; 169)** 18/18 (100%)
e extrastimuli (S1-5). In each animal was EP protocol made three times. HR
illation; NS,statistically non-significant; **P < 0.01; P ***P < 0.0001.
Figure 3 Comparison of electrophysiological parameters of RDN and control group. HR indicates heart rate; ERP, effective refractory period
of ventricles; VF, ventricular fibrillation; Control, control group; RDN, RDN group; NS, statistically non-significant; ** P < 0.01; P *** P < 0.0001.
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VF was induced using the same protocol in each attempt
in all animals of both RDN and Control groups (18/18
vs. 18/18) and also the median number of extrastimuli
did not differ. However, ERP was significantly pro-
longed in RDN group: 159 (150; 169) vs. 140 (133; 150)
ms, p = 0.001.Figure 4 Histological finding of renal artery 40 days after successful r
of the intima, the media and fragmentation of the lamina elastica externaDiscussion
In this experimental study we have shown that RDN chan-
ged autonomic control of the heart at interval of 40 days.
Decreased sympathetic activity was observed as pleiotropic
changes in the heart conduction system, e.g. decrease of the
rest heart rate, prolongation of atrioventricular conduction
and increase of ERP of ventricles.enal denervation. In the left portion of the image extensive fibrosis
and the adventicia depicted.
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myocardial excitability. By analogy with former experimen-
tal studies in dogs, surgical excision of the left stellate
ganglion prolonged ERP of 4–7 ms [22] and raised the VF
threshold [23]. This indicates that despite ablation of
perirenal sympathetic nerves, RDN has a similar effect as
the direct destruction of heart-related sympathetic ganglia
and nerves. Moreover, the antiarrhythmic effect of RDN
seems to be comparable to stimulation of the local
parasympathetic system. As described by André et al. [24],
stimulation of the vagal nerve on isolated rabbit hearts
in vitro prolonged ERP by 13% (vs. 14% in this study)
and VF threshold was significantly higher. In vivo data
demonstrated the anti-arrhythmic effect of vagal stimula-
tion especially in preventing decrease of VF threshold
during the stimulation of the sympathetic nerves [25].
Nevertheless, using the same PVS protocol we did
not prove the benefit of RDN in terms of decrease in
VF inducibility in this experimental setting (normal
porcine heart). According to previously published
clinical observational data by Bourke et al. [26], thoracic
epidural anesthesia or surgical left cardiac sympathetic
denervation allowed to reduce the incidence of ventricular
tachycardia (VT) by 68% in 14 patients with structural
heart disease refractory to pharmacotherapy and catheter
ablation. As mentioned above, Linz et al. [18] reported a
significant reduction of spontaneous ventricular extrabeats
and VF episodes during acute myocardial ischemia and
reperfusion in dogs after RDN. On the other hand, they
also discussed that using a beta-blocking agent (atenolol)
showed a comparable effect. In case reports by Ukena
[19] and Hoffmann [20] concerning patients with dilated/
hypertrophic cardiomyopathy or after acute myocardial
infarction, RDN was effective in decreasing VT/VF
events in addition to excessive antiarrhythmic medical
and ablation therapy.
We can hypothesize that the influence of RDN could
be more pronounced during the acute stress reaction
or in the presence of an arrhythmogenic substrate (e.g.
post-infarction scar) than in normal state. Also, our study
cannot address the superiority of RDN compared to the
use beta-blockers and other antiarrhythmic drugs.
As mentioned above, the study was limited by using
healthy animals not considering any predisposition
to ventricular arrhythmias like ischemic-reperfusion
injury or structural changes of the myocardium. Further,
electrophysiological parameters could be influenced by
depth of analgosedation, despite the effort to maintain the
same depth of anesthesia and similar dosage of propofol
and morphine. Also the number of tested experimental
animals was low and the electrophysiological study was
not performed in the same biomodel before and after
RDN because of presumed high morbidity-mortality of
biomodels during the 40-day period after the procedure.Thus, the translation of the results to humans should
be interpreted with caution despite the fact, that our
biomodels were represented by a breed repeatedly
validated for simulation of human cardiac arrest and
evaluation of VF [27,28].
Conclusions
We can conclude that renal denervation affected the
autonomic heart control significantly in favor of decreased
tone of the sympathetic nervous system in a healthy porcine
biomodel 40 days after RDN procedure. Unfortunately,
these changes were not associated with lower ventricular
fibrillation inducibility using the same PVS protocol in
comparison with the control group.
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